The London Stock Exchange uses cookies to improve its website. The cookies for analytical purposes have already been set. For more details and how to manage cookies, please see our privacy and cookies policy.

AZN ASTRAZENECA PLC ORD SHS $0.25



Income Statement  (£ m) 31-Dec-11 31-Dec-12 31-Dec-13 31-Dec-14 31-Dec-15
Continuing Operations
Revenue  20955.43 17654.57 16515.34 16153.38 16089.21
Operating Profit/(Loss)  7982.04 5142.44 2384.39 1300.33 2678.93
Net Interest  606.37 268.86 265.29 254.35 255.26
Profit Before Tax  7715.04 4825.61 2098.54 758.17 1998.45
Profit After Tax  6248.39 3957.18 1651.47 751.48 1840.22
Discontinued Operations
Profit After Tax  0.00 0.00 0.00 0.00 0.00
PROFIT FOR THE PERIOD  6248.39 3957.18 1651.47 751.48 1840.22
Attributable to:
Minority Interests  -20.59 -18.93 -9.64 -1.22 -0.65
Equity Holders of Parent Company  6227.80 3938.24 1641.84 750.26 1839.57
 
Continuing EPS
Earnings per Share - Basic  457.28p 312.41p 131.04p 59.63p 145.21p
Earnings per Share - Diluted  455.40p 311.78p 131.04p 59.63p 145.21p
Earnings per Share - Adjusted  457.28p 312.41p 131.04p 59.63p 145.21p
Continuing and Discontinued EPS
Earnings per Share - Basic  457.28p 312.41p 131.04p 59.63p 145.21p
Earnings per Share - Diluted  455.40p 311.78p 131.04p 59.63p 145.21p
Earnings per Share - Adjusted  457.28p 312.41p 131.04p 59.63p 145.21p
 
Dividend per Share  168.60p 181.70p 179.70p 169.90p 182.50p

Balance Sheet  (£ m) 31-Dec-11 31-Dec-12 31-Dec-13 31-Dec-14 31-Dec-15
Assets
Non-Current Assets
Property, Plant & Equipment  2236.66 3391.57 3060.64 3141.74 3270.33
Intangible Assets  13410.98 16207.94 15784.11 20900.63 23296.66
Investment Properties  0.00 0.00 0.00 0.00 0.00
Investments  129.34 122.42 170.41 360.43 366.52
Other Financial Assets  220.06 239.31 221.35 298.76 301.05
Other Non-Current Assets  2871.76 1254.38 2330.50 2217.21 2544.04
  18868.80 21215.63 21567.01 26918.78 29778.60
Current Assets
Inventories  1191.69 1267.92 1157.67 1259.27 1446.51
Trade & Other Receivables  6312.34 5187.33 5077.62 4857.82 4731.02
Cash at Bank & in Hand  4871.63 4737.62 5589.45 4086.20 4211.95
Current Asset Investments  2749.50 525.38 506.97 524.27 415.12
Other Current Assets  0.00 0.00 0.00 0.00 0.00
  15125.15 11718.24 12331.72 10727.55 10804.59
 
Total Assets  33993.95 32933.87 33898.73 37646.33 40583.19
 
Liabilities
Current Liabilities
Borrowings  -1280.48 -554.29 -1084.29 -1571.52 -618.29
Other Current Liabilities  -8855.28 -7998.77 -8649.49 -9562.73 -9418.16
  -10135.77 -8553.06 -9733.78 -11134.24 -10036.45
 
Net Current Assets  4989.39 3165.18 2597.94 -406.69 768.14
 
Non-Current Liabilities
Borrowings  -4721.70 -5788.37 -5208.00 -5394.94 -9542.36
Provisions  -2064.86 -1848.05 -2057.61 -1464.86 -2144.45
Other Non-Current Liabilities  -1968.34 -2012.92 -2798.06 -7030.06 -6366.52
  -8754.91 -9649.34 -10063.67 -13889.85 -18053.32
 
Other Liabilities  n/a n/a n/a n/a n/a
Total Liabilities  -18890.67 -18202.40 -19797.45 -25024.09 -28089.77
 
Net Assets  15103.28 14731.47 14101.27 12622.23 12493.42
 
Capital & Reserves
Share Capital  207.84 191.94 191.03 203.03 213.30
Share Premium Account  1980.57 2155.64 2415.40 2737.62 2905.16
Other Reserves  1255.39 1205.78 1192.24 1298.46 1374.28
Retained Earnings  11514.06 11045.83 10285.02 8370.92 7987.85
Shareholders Funds  14957.85 14599.20 14083.69 12610.03 12480.59
 
Minority Interests/Other Equity  145.42 132.27 17.59 12.21 12.83
Total Equity  15103.28 14731.47 14101.27 12622.23 12493.42

Ratios - based on IFRS 31-Dec-11 31-Dec-12 31-Dec-13 31-Dec-14 31-Dec-15
Continuing Operations
PE Ratio - Adjusted  6.51 9.31 27.28 76.40 31.79
PEG - Adjusted  1.24 -0.29 -0.47 -1.40 0.22
Earnings per Share Growth - Adjusted  5.25% -31.68% -58.06% -54.49% 143.52%
Dividend Cover  2.71 1.72 0.73 0.35 0.80
Revenue Per Share  1539.71p 1400.05p 1319.12p 1279.98p 1272.88p
Pre-Tax Profit per Share  566.87p 382.68p 167.62p 60.08p 158.11p
Operating Margin  39.67% 28.83% 14.12% 6.11% 13.89%
Return on Capital Employed  72.49% 62.81% 29.41% 49.42% 79.52%
 
Continuing & Discontinued Operations
Dividend Yield  5.67% 6.25% 5.03% 3.73% 3.95%
Dividend per Share Growth  12.18% 7.77% -1.10% -5.45% 7.42%
Net Asset Value per Share (exc. Intangibles)  119.69p -129.01p -135.26p -656.35p -855.62p
Net Gearing  7.56% 10.99% 4.99% 22.84% 47.66%

Data is provided by Morningstar



Company Information
Updated Monthly
Company address Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge, CB2 0AA, United Kingdom
Company website http://www.astrazeneca....
Market cap(in millions)* £ 63,438.15
Listing/Admission to trading 01 Jun 1993
Trading service SETS
Market Main Market
Listing category Premium Equity Commercial Companies
*The market capitalisation of companies reflects the London listed element only. These figures are approximate and are updated monthly.

Trading Information
29-Jul-16
FTSE index FTSE All-Share,FTSE Eurotop 300,FTSE 350 High Yield,FTSE 100,FTSE 350 (ex IT),FTSE techMARK All-Share,FTSE All-Share (ex IT),FTSE 350
FTSE sector Pharmaceuticals & Biotechnology
FTSE sub-sector Pharmaceuticals
Country of share register GB
Segment SET0
MiFID Status Regulated Market
Exchange market size 500
SEDOL 0989529
ISIN number GB0009895292



ASTRAZENECA share fundamentals (AZN)